11:09 AM EST, 01/27/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were treading water late Monday morning, edging 0.04% higher to 1,357.59 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biotech firm Evaxion Biotech ( EVAX ) and telecommunications company Ericsson (ERIC), which rose 5% and 3.6%, respectively. They were followed by medical device maker EDAP (EDAP) and biopharmaceutical company DBV Technologies ( DBVT ) , which were up 3.1% and 2.8%, respectively.

The decliners from continental Europe were led by semiconductor company Sequans Communications ( SQNS ) and internet browser company Opera (OPRA), which dropped 3.8% and 3.3%, respectively. They were followed by biopharmaceutical company Grifols ( GRFS ) and pharmaceutical company Novo Nordisk ( NVO ) , which lost 1.8% and 1.2%, respectively.

From the UK and Ireland, the gainers were led by consumer goods company British American Tobacco ( BTI ) and biopharmaceutical company Bicycle Therapeutics ( BCYC ) , which increased 3.2% and 2.9%, respectively. They were followed by pharmaceutical companies GSK (GSK) and Silence Therapeutics ( SLN ) , which advanced 2.8% and 2.6%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Biodexa Pharmaceuticals ( BDRX ) and TC Biopharm ( TCBP ) , which shed 9.7% and 4.3%, respectively. They were followed by biopharmaceutical company NuCana ( NCNA ) and biotech firm Trinity Biotech ( TRIB ) , which fell 3.5%, each.